Zimmer Biomet Announces Second Quarter 2026 Financial Results

EarningsPositive

AI Analysis

Summary

Zimmer Biomet reported second quarter 2026 net sales of $2.177 billion, up 4.8% on a reported basis, with diluted EPS of $1.03 and adjusted diluted EPS of $2.07.

Financial Highlights

Revenue

$2.177 billion

EPS

$1.03 diluted, $2.07 adjusted diluted

Importance:3/10

Sentiment:

0.50

earningsQ2_2026financial_resultsrevenue_growth

Related Companies

$ZBH

Read the original article

Published by PR Newswire Biotech on August 5, 2026 10:30 AM

Read Original